Hosted on MSN5mon
Galderma reports data from Phase III trial of anti-ageing product RelabotulinumtoxinASwiss skincare company Galderma has reported positive data from a Phase III clinical trial of RelabotulinumtoxinA (Relfydess) for treating moderate-to-severe frown lines and crow's feet.
4mon
First for Women on MSNNew Injection Membership Is Available for $49 a Month: How It WorksThe secret to wrinkle-free, smooth skin isn't so secret in today's day and age. More than ever, people are turning to Botox or other neurotoxin injections, the muscle relaxers that help prevent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results